Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association

@article{Jaff2011ManagementOM,
  title={Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association},
  author={M. Jaff and M. S. McMurtry and S. Archer and M. Cushman and N. Goldenberg and S. Goldhaber and J. Jenkins and J. Kline and A. Michaels and P. Thistlethwaite and S. Vedantham and R. J. White and B. Zierler},
  journal={Circulation},
  year={2011},
  volume={123},
  pages={1788–1830}
}
  • M. Jaff, M. S. McMurtry, +10 authors B. Zierler
  • Published 2011
  • Medicine
  • Circulation
  • Venous thromboembolism (VTE) is responsible for the hospitalization of >250 000 Americans annually and represents a significant risk for morbidity and mortality. Despite the publication of evidence-based clinical practice guidelines to aid in the management of VTE in its acute and chronic forms, the clinician is frequently confronted with manifestations of VTE for which data are sparse and optimal management is unclear. In particular, the optimal use of advanced therapies for acute VTE… CONTINUE READING
    1,400 Citations

    Paper Mentions

    Interventional Clinical Trial
    To determine whether peripheral low dose systemic thrombolysis (PLST) is non-inferior to catheter directed acoustic pulse thrombolysis (ACDT) in improving RV function and reducing… Expand
    ConditionsPulmonary Embolism, Pulmonary Hypertension, Right Ventricular Dysfunction, (+1 more)
    InterventionDevice, Drug
    Interventional Clinical Trial
    The study will compare standard catheter directed thrombolysis to ultrasound accelerated thrombolysis for the treatment of acute submassive pulmonary embolism (PE). The study… Expand
    ConditionsPulmonary Embolism
    InterventionProcedure
    Interventional Clinical Trial
    Acute pulmonary embolism (PE) accounts for 5-10% of in-hospital deaths. Systemic anticoagulation (AC) is the standard of care and thrombolysis is recommended for those at a higher… Expand
    ConditionsSubmassive Pulmonary Embolism
    InterventionProcedure
    Observational Clinical Trial
    Acute pulmonary embolism (PE) is a condition in which the vessels carrying blood to the lungs become suddenly blocked, usually by a blood clot. There are a number of adverse consequences… Expand
    ConditionsPulmonary Embolism, Right Ventricular Failure
    InterventionDiagnostic Test
    Management of Pulmonary Embolism: State of the Art Treatment and Emerging Research
    • 7
    Pathogenesis of Thromboembolism and Endovascular Management
    • 21
    • PDF
    An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension.
    • 13
    Recent advances in chronic thromboembolic pulmonary hypertension.
    • 8
    The Elusive Evidence for Inferior Vena Cava Filters to Prevent Pulmonary Embolism.
    • 6
    Acute pulmonary embolism unmasking underlying chronic thromboembolic pulmonary hypertension and iliac vein compression syndrome

    References

    SHOWING 1-10 OF 554 REFERENCES
    Assessment of operability in chronic thromboembolic pulmonary hypertension.
    • N. Kim
    • Medicine
    • Proceedings of the American Thoracic Society
    • 2006
    • 100
    Catheter embolectomy for acute pulmonary embolism.
    • 99
    Chronic thromboembolic pulmonary hypertension.
    • 26
    Risk factors for chronic thromboembolic pulmonary hypertension
    • 190
    • PDF
    Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
    • 1,539
    • PDF